To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
May 2021

Efficacy of High-Flow Nasal Cannula Oxygen Therapy for Patients with Severe COVID-19

Vol: 32| Issue: 1| Number:4| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The value of high-flow nasal cannula oxygen therapy in treating novel coronavirus pneumonia

Eur J Clin Invest. 2020 Oct 31 : e13435.

Contributing Authors:
XB Teng Y Shen MF Han G Yang L Zha JF Shi

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Twenty-two patients hospitalized with severe COVID-19 were randomized to receive oxygen therapy using a high-flow nasal cannula oxygen system (n=22) or conventional oxygen therapy (n=10). Outcomes of interest included vitals (i.e., heart rate; respiratory rate; PaO2/FiO2 oxygenation index), infection indexes (C-reactive protein [CRP]; procalcitonin [PCT]; white blood cell count; lymphocyte count),...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.